FDA Import Refusal AEK-5552871-3/11/1 — ACCENT PHARMA

ACCENT PHARMA — FEI 3017520222

The FDA refused shipment AEK-5552871-3/11/1 from ACCENT PHARMA (India) on August 9, 2024. The refused product falls under Drugs and Biologics — METFORMIN (ANTI-DIABETIC). Cited charge: 75 This firm has 2 other import refusals on record.